Evidence map›Paper›PMID 41589039›Full record

ArticleInternational journal of fertility & sterility2026

Fabrication and Characterization of Xylomannan/Fe

Meisam Jangkhah, Pegah Shayegh, MohammadReza Ghalamboran, Rouhollah Fathi

Abstract read
In one paragraph

Article in International journal of fertility & sterility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meisam JangkhahDepartment of Developmental Biology, School of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran.
Pegah ShayeghDepartment of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
MohammadReza GhalamboranDepartment of Plant Sciences and Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran. Email: m_ghalamboran@sbu.ac.ir.ORCID 0000-0003-3865-8636
Rouhollah FathiDepartment of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Email: rfathi79@royaninstitute.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nano-biotechnology is a rapidly evolving field merging biology, engineering, and chemistry. Nanoparticles (NPs) with low toxicity and diverse properties, hold great promise for cryopreservation. Their ability to modify membrane permeability, optimize cryoprotectant entry and removal, tolerate freezing temperatures, enhance warming efficiency, and improve the heat transfer and thermodynamic properties of cryo-solution, makes them a game-changer for low-temperature preservation. This study investigated the potential of Fe Materials and Methods: This study is experimental research. Xylomannan, a polysaccharide derived from Enoki mushroom, exhibits cryoprotective properties. The nanocomposite was synthesized by coating Fe Results: The cytotoxicity of different concentrations (0.002, 0.004, 0.008 and 0.016%) of Xylomannan, Fe Conclusion: The findings of this study reveal the potential of Fe

Indexed as

FeMouse OocyteNanocomposite SynthesisViabilityXylomannan

Identifiers

PMID41589039
PMCPMC12831590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.